QUESTLAB
Start SIP
Invest Now
Start SIP in QUESTLAB
Performance
- Low
- ₹102
- High
- ₹108
- 52 Week Low
- ₹75
- 52 Week High
- ₹160
- Open Price₹103
- Previous Close₹100
- Volume51,600
Investment Returns
- Over 1 Month + 20.56%
- Over 3 Month + 11.27%
- Over 6 Month + 24.07%
- Over 1 Year -0.29%
Smart Investing Starts Here Start SIP with Quest Laboratories for Steady Growth!
Quest Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 12.6
- PEG Ratio
- -
- Market Cap Cr
- 172
- P/B Ratio
- 1.9
- Average True Range
- 4.96
- EPS
- 8.63
- Dividend Yield
- 0
- MACD Signal
- 2.56
- RSI
- 65.14
- MFI
- 87.41
Quest Laboratories Financials
Quest Laboratories Technicals
EMA & SMA
Current Price
₹104.65
+
4.65
(4.65%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹95.21
- 50 Day
- ₹92.37
- 100 Day
- ₹93.56
- 200 Day
- ₹98.83
Resistance and Support
104.87
- R3 113.68
- R2 110.82
- R1 107.73
- S1 101.78
- S2 98.92
- S3 95.83
Quest Laboratories Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-28 | Audited Results | |
| 2025-01-27 | Others | To consider other business matters. |
| 2024-11-14 | Quarterly Results & Others | To consider other business matters. |
Quest Laboratories F&O
About Quest Laboratories
- NSE Symbol
- QUESTLAB
- BSE Symbol
- Chairman & Managing Director
- Mr. Anil Kumar Sabarwal
- ISIN
- INE0TNW01017
Similar Stocks to Quest Laboratories
Quest Laboratories FAQs
Quest Laboratories share price is ₹104 As on 30 December, 2025 | 23:57
The Market Cap of Quest Laboratories is ₹171.5 Cr As on 30 December, 2025 | 23:57
The P/E ratio of Quest Laboratories is 12.6 As on 30 December, 2025 | 23:57
The PB ratio of Quest Laboratories is 1.9 As on 30 December, 2025 | 23:57
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.